AdopTracell is an emerging preclinical stage company developing next-generation autoimmune therapies with the potential to profoundly improve patient outcomes. We are building a pipeline of targeted regulatory T-cell therapies, with a preliminary focus on Type 1 Diabetes.
| Website | https://www.adoptracell.com/ |
| Employees | 1 (0 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular adopTracell employee's phone or email?